Open access
Open access
Powered by Google Translator Translator

[Preprint] RCT: Full-dose/therapeutic anticoagulation provides no benefit in critically ill patients with Covid-19

14 Mar, 2021 | 20:59h | UTC

Therapeutic Anticoagulation in Critically Ill Patients with Covid-19-Preliminary Report – medRxiv

Commentary: PulmCrit Wee – Therapeutic anticoagulation for COVID ICU patients: Is the heparin vial half empty, or half full?

Related (results on moderately ill patients): [Not published yet] Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials

 


Stay Updated in Your Specialty

No spam, just news.